Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

MYL Insider Trading

MYL | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at MYL provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2011-08-11 19:24 2011-08-11 COURY ROBERT J Director, Officer - Chairman, CEO BUY $17.99 5,000 $89,950 786,964 +0.6%
2011-08-10 23:10 2011-08-10 COURY ROBERT J Director, Officer - Chairman, CEO BUY $17.46 10,000 $174,600 781,964 +1.3%
2011-08-05 18:05 2011-08-03 Piatt Rodney L Director BUY $20.81 5,000 $104,050 52,652 +10.5%
2011-05-07 03:04 2011-05-06 TODD C B Director OPT+S $24.08 247,502 $5,960,739 1,686 0.0%
2011-05-06 23:55 2011-05-06 LEECH DOUGLAS J Director OPT+S $24.09 8,438 $203,271 25,821 0.0%
2011-03-28 23:40 2011-03-28 Malik Rajiv Officer - EVP & Chief Operating Officer OPT+S $22.30 1,820 $40,586 144,024 0.0%
2011-03-21 23:47 2011-03-18 Malik Rajiv Officer - EVP & Chief Operating Officer OPT+S $21.98 21,527 $473,163 140,184 0.0%
2011-03-05 00:51 2011-03-04 Malik Rajiv Officer - EVP & Chief Operating Officer OPT+S $22.95 2,065 $47,392 94,626 0.0%
2010-06-16 00:21 2010-06-15 TODD C B Director OPT+S $18.02 67,500 $1,216,073 28,686 0.0%
2010-03-06 00:56 2010-03-03 Malik Rajiv Officer - Chief Operating Officer OPT+S $21.15 80,000 $1,692,056 61,227 0.0%
2009-12-12 00:52 2009-12-11 LEECH DOUGLAS J Director OPT+S $18.49 16,875 $312,054 11,331 0.0%
2009-03-21 00:17 2009-03-20 Malik Rajiv Officer - Exec. VP, Global Tech. Ops. OPT+S $13.20 5,690 $75,108 41,338 0.0%
2009-02-25 19:08 2009-02-25 COURY ROBERT J Director, Officer - Vice Chairman, CEO BUY $12.97 10,000 $129,719 472,192 +2.2%
2009-02-24 19:29 2009-02-24 COURY ROBERT J Director, Officer - Vice Chairman, CEO BUY $12.90 15,000 $193,484 462,192 +3.4%
2009-02-24 16:43 2009-02-23 Piatt Rodney L Director BUY $12.83 5,000 $64,150 30,000 +20.0%
2009-02-23 18:02 2009-02-23 COURY ROBERT J Director, Officer - Vice Chairman, CEO BUY $12.86 25,000 $321,620 447,192 +5.9%
2008-03-17 19:09 2008-03-17 MAROON JOSEPH C MD Director BUY $11.00 2,000 $22,000 6,000 +50.0%
2008-03-17 15:28 2008-03-14 Malik Rajiv Officer - Head of Global Tech. Ops. BUY $10.96 5,000 $54,798 15,000 +50.0%
2008-03-13 22:01 2008-03-13 CAMERON WENDY Director BUY $10.64 5,000 $53,200 18,700 +36.5%
2008-03-13 21:55 2008-03-13 DIMICK NEIL F Director BUY $10.58 4,700 $49,719 4,700 +100.0%
2008-03-11 17:20 2008-03-10 Piatt Rodney L Director BUY $10.38 5,000 $51,900 24,400 +25.8%
2008-03-11 16:18 2008-03-10 BRESCH HEATHER M Officer - Chief Operating Officer BUY $10.39 5,000 $51,950 13,695 +57.5%
2008-03-10 21:11 2008-03-10 BORKOWSKI EDWARD Officer - Chief Financial Officer BUY $10.38 5,000 $51,900 56,775 +9.7%
2008-03-10 20:27 2008-03-07 WILLIAMS STUART A Officer - Special Counsel, Office of CEO BUY $10.55 10,000 $105,500 110,433 +10.0%
2008-03-07 21:03 2008-03-07 COURY ROBERT J Director, Officer - Vice Chairman, CEO BUY $10.14 20,000 $202,800 571,217 +3.6%
2008-03-06 18:57 2008-03-06 COURY ROBERT J Director, Officer - Vice Chairman, CEO BUY $10.74 10,000 $107,400 551,217 +1.8%
2008-03-05 21:55 2008-03-05 COURY ROBERT J Director, Officer - Vice Chairman, CEO BUY $10.91 15,000 $163,650 541,217 +2.9%
2007-08-27 18:08 2007-08-02 MAROON JOSEPH C MD Director BUY $15.52 4,000 $62,068 4,000 +100.0%
2007-08-10 17:39 2007-08-10 COURY ROBERT J Director, Officer - Vice Chairman, CEO BUY $14.02 10,000 $140,200 526,217 +1.9%
2007-08-08 22:39 2007-08-08 Piatt Rodney L Director BUY $15.04 4,400 $66,164 19,400 +29.3%
2007-08-08 20:17 2007-08-08 WILLIAMS STUART A Officer - Chief Legal Officer BUY $14.87 5,000 $74,335 100,433 +5.2%
2007-08-06 14:36 2007-08-03 WILLIAMS STUART A Officer - Chief Legal Officer BUY $15.72 15,000 $235,850 95,433 +18.6%
2007-07-31 23:28 2007-07-27 CAMERON WENDY Director BUY $16.10 6,200 $99,820 13,700 +82.7%
2007-07-27 19:32 2007-07-27 TODD C B Director BUY $16.74 10,000 $167,429 1,686 +100.0%
2007-07-27 19:22 2007-07-27 Piatt Rodney L Director BUY $16.68 5,000 $83,400 15,000 +50.0%
2007-07-27 19:06 2007-07-27 COURY ROBERT J Director, Officer - Vice Chairman, CEO BUY $16.74 20,000 $334,858 363,263 +5.8%
2007-06-18 16:02 2007-06-15 COURY ROBERT J Director, Officer - Vice Chairman, CEO BUY $18.54 15,000 $278,150 343,263 +4.6%
2007-06-18 15:49 2007-06-15 BORKOWSKI EDWARD Officer - Chief Financial Officer BUY $18.56 5,000 $92,800 51,775 +10.7%
2007-06-15 18:59 2007-06-15 COURY ROBERT J Director, Officer - Vice Chairman, CEO BUY $18.60 20,000 $371,900 328,263 +6.5%
2007-06-14 22:45 2007-06-14 COURY ROBERT J Director, Officer - Vice Chairman, CEO BUY $18.44 15,000 $276,645 308,263 +5.1%
2007-06-14 01:02 2007-06-12 Piatt Rodney L Director BUY $18.65 4,000 $74,600 10,000 +66.7%
2007-02-17 01:39 2007-02-15 Nimmagadda Prasad Director, Officer - Head of Global Strategies BUY $20.85 1,199,039 $24,999,963 1,199,039 +100.0%
2007-02-03 01:33 2007-02-01 WILLIAMS STUART A Officer - Chief Legal Officer OPT+S $22.24 75,000 $1,668,000 80,433 0.0%
2007-01-25 01:19 2007-01-22 WILLIAMS STUART A Officer - Chief Legal Officer OPT+S $21.00 75,000 $1,575,000 80,433 0.0%
2006-12-16 01:16 2006-12-14 KORMAN HARRY Officer - Pres., Mylan Pharmaceuticals OPT+S $20.62 120,000 $2,474,796 16,748 0.0%
2006-11-25 01:15 2006-11-21 ODONNELL JOHN Officer - Chief Scientific Officer SELL $20.56 20,000 $411,232 27,047 -42.5%
2006-09-20 00:11 2006-09-15 SPHAR GARY Officer - CFO, Mylan Pharmaceuticals Inc OPT+S $21.20 8,100 $171,700 5,045 0.0%
2006-09-14 23:47 2006-09-12 ODONNELL JOHN Officer - Chief Scientific Officer OPT+S $20.36 100,000 $2,035,940 47,047 0.0%
2006-04-05 23:57 2006-04-03 WILLIAMS STUART A Officer - Chief Legal Officer OPT+S $23.55 25,000 $588,750 83,558 0.0%
2006-03-04 00:42 2006-03-01 WILLIAMS STUART A Officer - Chief Legal Officer OPT+S $22.90 40,000 $916,000 83,558 0.0%
SHOW ENTRIES
101-150 OF 185

How to Interpret $MYL Trades

Not every insider transaction in MYL is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $MYL shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for MYL

Insider activity data for MYL is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $MYL, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.